3//SEC Filing
Blue Horizon Enterprise Ltd 3
Accession 0001123292-21-001060
CIK 0001623526other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:14 PM ET
Size
9.9 KB
Accession
0001123292-21-001060
Insider Transaction Report
Form 3
Skorpios Trust
10% Owner
Holdings
- 14,443,681(indirect: See Footnote)
Common Stock
Montrago Trustees Ltd
10% Owner
Holdings
- 14,443,681(indirect: See Footnote)
Common Stock
Blue Horizon Enterprise Ltd
10% Owner
Holdings
- 14,443,681(indirect: See Footnote)
Common Stock
Ezbon International Ltd
10% Owner
Holdings
- 14,443,681(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,346,298 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 2,561,531 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001869057
Filing Metadata
- Form type
- 3
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:14 PM ET
- Size
- 9.9 KB